Celcuity (CELC) Other Non-Current Assets (2017 - 2025)

Celcuity (CELC) posted Other Non-Current Assets of $349000.0 for Q4 2025, up 598.0% on a QoQ basis from $50000.0 in Q2 2018.

Celcuity (CELC) Other Non-Current Assets (2017 - 2025) Analysis & Trends

Celcuity's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $349000.0 for Q4 2025.

Quarterly Other Non-Current Assets changed N/A year-over-year to $349000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $349000.0 (changed N/A YoY) and the FY2025 annual result came in at $349000.0, changed N/A from the prior year.
Other Non-Current Assets was $349000.0 for Q4 2025 at Celcuity, up from $50000.0 in the prior quarter.
Across five years, Other Non-Current Assets topped out at $349000.0 in Q4 2025 and bottomed at $349000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	1.02 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	104.24 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.26 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	2.13 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	289.41 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	124.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	14.48 Mn
10	Celcuity	4.13 Bn	4.13 Bn	-	349,000.00

Download Data